Do we need to assess the effect of treatment withdrawal? The paradigm of life-long prevention.
Gueyffier
François
F
Bejan-Angoulvant
Théodora
T
D002545:Brain Ischemia / Q000401:mortality* / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D020521:Stroke / Q000401:mortality* / Q000517:prevention & control; D013375:Substance Withdrawal Syndrome / Q000401:mortality*
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors